Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400087605Phase 4Not yet recruiting
Phase 4 trial of fospropofol disodium in pain, agitation and delirium (3 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoints: Time to achieve sedation goal, Mechanical ventilation duration and 2 more. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400087605.